| LYKAN BIOSCIENCE Lykan Bioscience Holdings, LLC
88889833 27 Apr 2020 | on 15 Feb 2022
| Custom manufacture of pharmaceuticals by pharmaceutical compounders; c... Class 040 Class 040 Treatment & Processing of Materials Services Custom manufacture of pharmaceuticals by pharmaceutical compounders; custom manufacture of chemotherapy drugs by pharmaceutical compounders | | | TRANSFORMING THE FUTURE TOGETHER Lykan Bioscience Holdings, LLC
88889649 27 Apr 2020 | on 15 Jun 2021
| Custom manufacture of chemotherapy drugs by pharmaceutical compounders... Class 040 Class 040 Treatment & Processing of Materials Services Custom manufacture of chemotherapy drugs by pharmaceutical compounders; Custom manufacture of pharmaceuticals by pharmaceutical compounders | | | LYKAN BIOSCIENCE LYKAN BIOSCIENCE HOLDINGS, LLC
88731246 18 Dec 2019 | on 09 Feb 2021
| Custom manufacture of pharmaceuticals by pharmaceutical compounders; C... Class 040 Class 040 Treatment & Processing of Materials Services Custom manufacture of pharmaceuticals by pharmaceutical compounders; Custom manufacture of chemotherapy drugs by pharmaceutical compounders | | | Logo Mark LYKAN BIOSCIENCE HOLDINGS, LLC
88731241 18 Dec 2019 | on 09 Feb 2021
| Custom manufacture of pharmaceuticals by pharmaceutical compounders; C... Class 040 Class 040 Treatment & Processing of Materials Services Color is not claimed as a feature of the mark. | | | AKCESS CLEARVIEW Lykan Bioscience Holdings, LLC
88890959 28 Apr 2020 | on 03 Jan 2022 | Downloadable mobile applications for viewing and managing manufacturin... Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Downloadable mobile applications for viewing and managing manufacturing timelines, documentation, audits, operations progress reports, and key performance indicator data, all in the field of custom manufacture of pharmaceuticals and chemotherapy drugs by pharmaceutical compounders; Downloadable computer software for viewing and managing manufacturing timelines, documentation, audits, operations progress reports, and key performance indicator data, all in the field of custom manufacture of pharmaceuticals and chemotherapy drugs by pharmaceutical compounders | |